[1] |
Kubo S, Yamaji K, Inohara T, et al. In-hospital outcomes after percutaneous coronary intervention for acute coronary syndrome with cardiogenic shock (from a Japanese nationwide registry [J-PCI registry])[J]. Am J Cardiol, 2019, 123(10):1595-1601.
|
[2] |
孙阳阳,隋萍,刘晓红,等.急性冠脉综合征患者PCI术后1年发生不良心血管事件风险预测模型的构建及评价[J].护理学报,2020,27(19):11-16.
|
[3] |
李云鸿,杜书敏,段宗刚,等.PCI术后非ST段抬高型急性冠脉综合征患者再发不良心血管事件的危险因素分析[J].贵州医科大学学报,2020,45(5):573-578.
|
[4] |
刘琛,李凤德,杨红红.老年急性心肌梗死再发的现状调查及影响因素分析[J].心肺血管病杂志,2020,39(10):1188-1192.
|
[5] |
葛均波,徐永健,王辰.内科学[M].9版.北京:人民卫生出版社,2018:229-245.
|
[6] |
中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会,血栓防治专业委员会,等.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400.
|
[7] |
Song J, Murugiah K, Hu S, et al.Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China[J]. Heart, 2020, 107(4):313-318.
|
[8] |
Qin Y, Wei X, Han H, et al. Association between age and readmission after percutaneous coronary intervention for acute myocardial infarction[J]. Heart, 2020, 106(20):1595-1603.
|
[9] |
郭浩,齐茗.高危急性冠脉综合征患者PCI术后不良心血管事件发生的影响因素[J].解放军预防医学杂志,2019,37(11):59-60.
|
[10] |
陈望姣.H型高血压与初发急性心肌梗死患者近期预后的关系[J].实用临床医药杂志,2019,23(10):39-41.
|
[11] |
熊国均,黄楷森,欧荣华,等.纤维蛋白原与白蛋白比值对多支血管病变性急性心肌梗死患者PCI术后远期预后的预测价值[J].疑难病杂志,2019,18(12):1212-1217.
|
[12] |
Song J, Yu T, Sun Z, et al. Comparison of prognostic significance between serum fibrinogen and Global Registry of Acute Coronary Events score for prognosis of patients with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention[J]. Coron Artery Dis, 2020, 31(2):124-129.
|
[13] |
赵一品,季莹莹,王丰云,等.纤维蛋白原与白蛋白比值预测急性ST段抬高型心肌梗死患者梗死相关动脉自发再通的价值[J].中华心血管病杂志,2019,47(2):123-128.
|
[14] |
Revnic C, Nica AS, Revnic F, et al. Relationship between matrix metalloproteinases mmp-9, mmp-7, their inhibitors, hs crp and severity of atherosclerotic coronary artery disease[J/OL]. J Hypertens, 2017, 35(2):e294.
|
[15] |
Lekic A, Brekalo Z, Kvesic A, et al. Crosstalk between enzyme matrix metalloproteinases 2 and 9 and regulatory t cell immunity in the global burden of atherosclerosis[J]. Scand J Immunol, 2017, 86(1):65-71.
|
[16] |
Deveci B, Gazi E. Relation between globulin, fibrinogen, and albumin with the presence and severity of coronary artery disease[J]. Angiology, 2020, 72(2):174-180.
|
[17] |
Karabağ Y, Çağdaş M, Rencuzogullari I, et al. Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris[J/OL]. J Clin Lab Anal, 2018, 32(7):e22457.
|